Pyxis Oncology, Inc.
45 SEC EDGAR filings indexed (CIK 0001782223) across 13 form types.
Filing profile
Pyxis Oncology, Inc. (PYXS) has 45 SEC filings indexed on SecFilingDex, across 13 form types filed over roughly 3 years, from March 21, 2024 to October 9, 2026. The filer is classified under Pharmaceutical Preparations (SIC 2834).
Its most frequent disclosure is the Form 4 (Insider transaction) with 8 filings — Statement of changes in beneficial ownership filed by company officers, directors, and 10%+ owners. 27 of these filings were disclosed in the twelve months to October 9, 2026. 4 of the 45 are amendments (a corrected or updated version of an earlier filing).
Disclosure mix
- 8Form 4Insider transaction · within 2 business days of transaction
- 88-KMaterial event · event-driven
- 810-QQuarterly report · quarterly
- 4DEF 14AProxy statement · annual (pre-meeting)
- 3DEFA14ASEC filing
- 310-KAnnual report · annual
- 2PRE 14ASEC filing
- 2424B5Prospectus supplement · event-driven
- 2Form 3Initial insider ownership · within 10 days of becoming an insider
- 2SC 13G/A5%+ passive stake · event-driven
- 18-K/AMaterial event · event-driven
- 1424B2Shelf prospectus · event-driven
- 1SC 13D/A5%+ activist stake · event-driven (within 10 days)
Profile derived from 45 indexed filings; every figure traces to the filing records above, each linking back to its original SEC EDGAR document. Filing counts reflect SecFilingDex's current index, not the filer's complete EDGAR history.
All filings
- PRE 14ASEC filingFiled · 0001193125-26-419208
- 424B5Prospectus supplementFiled · 0001437749-26-031667
- 424B5Prospectus supplementFiled · 0001437749-26-031480
- Form 4Insider transaction · period of report Aug 20, 2026Filed · 0001193125-26-359525
- Form 4Insider transaction · period of report Aug 12, 2026Filed · 0001193125-26-352206
- 8-KMaterial event · period of report Aug 13, 2026Filed · 0001193125-26-347911
- 10-QQuarterly report · period of report Jun 30, 2026Filed · 0001193125-26-347913
- Form 3Initial insider ownership · period of report Jun 30, 2026Filed · 0000919574-26-004386
- 8-KMaterial event · period of report Jun 30, 2026Filed · 0001193125-26-294613
- Form 4Insider transaction · period of report Jun 30, 2026Filed · 0001193125-26-294708
- 8-KMaterial event · period of report Jun 15, 2026Filed · 0001193125-26-271137
- 8-KMaterial event · period of report May 14, 2026Filed · 0001193125-26-222818
- 10-QQuarterly report · period of report Mar 31, 2026Filed · 0001193125-26-222843
- 8-K/AMaterial eventFiled · 0001193125-26-193940
- DEF 14AProxy statement · period of report Apr 30, 2026Filed · 0001193125-26-194032
- DEFA14ASEC filingFiled · 0001193125-26-194051
- Form 4Insider transaction · period of report Mar 24, 2026Filed · 0001193125-26-124333
- Form 4Insider transaction · period of report Mar 24, 2026Filed · 0001193125-26-124342
- Form 4Insider transaction · period of report Mar 24, 2026Filed · 0001193125-26-124348
- Form 4Insider transaction · period of report Mar 24, 2026Filed · 0001193125-26-124380
- Form 4Insider transaction · period of report Mar 24, 2026Filed · 0001193125-26-124388
- 8-KMaterial event · period of report Mar 23, 2026Filed · 0001193125-26-118525
- 10-KAnnual report · period of report Dec 31, 2025Filed · 0001193125-26-118532
- 8-KMaterial event · period of report Feb 6, 2026Filed · 0001193125-26-041169
- 8-KMaterial event · period of report Dec 18, 2025Filed · 0001193125-25-323704
- 8-KMaterial event · period of report Nov 3, 2025Filed · 0001193125-25-261689
- 10-QQuarterly report · period of report Sep 30, 2025Filed · 0001193125-25-261696
- 10-QQuarterly report · period of report Jun 30, 2025Filed · 0000950170-25-108906
- 10-QQuarterly report · period of report Mar 31, 2025Filed · 0000950170-25-071996
- DEF 14AProxy statement · period of report Apr 29, 2025Filed · 0000950170-25-059573
- DEFA14ASEC filingFiled · 0000950170-25-059575
- 10-KAnnual report · period of report Dec 31, 2024Filed · 0000950170-25-040771
- 10-QQuarterly report · period of report Sep 30, 2024Filed · 0000950170-24-124602
- SC 13G/A5%+ passive stakeFiled · 0001085146-24-005529
- SC 13G/A5%+ passive stakeFiled · 0001104659-24-114823
- DEF 14AProxy statement · period of report Sep 25, 2024Filed · 0000950170-24-109337
- PRE 14ASEC filing · period of report Sep 13, 2024Filed · 0000950170-24-106381
- 10-QQuarterly report · period of report Jun 30, 2024Filed · 0000950170-24-097073
- Form 3Initial insider ownership · period of report Jun 10, 2024Filed · 0000950170-24-071435
- 10-QQuarterly report · period of report Mar 31, 2024Filed · 0000950170-24-059099
- DEF 14AProxy statement · period of report Jun 11, 2024Filed · 0000950170-24-049154
- DEFA14ASEC filingFiled · 0000950170-24-049161
- 424B2Shelf prospectusFiled · 0001437749-24-010967
- SC 13D/A5%+ activist stakeFiled · 0000950170-24-041264
- 10-KAnnual report · period of report Dec 31, 2023Filed · 0000950170-24-034868
Authoritative source
SecFilingDex republishes EDGAR data with provenance. EDGAR is authoritative; this page reflects the most recent index pull.
Disclaimer: SecFilingDex is independent and not affiliated with the U.S. Securities and Exchange Commission. Nothing on this page is investment, legal, or tax advice.